• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

七种市售脱矿骨基质纤维和糊剂产品在大鼠后外侧融合模型中的性能

Performance of Seven Commercially Available Demineralized Bone Matrix Fiber and Putty Products in a Rat Posterolateral Fusion Model.

作者信息

Russell Nicholas, Walsh William R, Lovric Vedran, Kim Peter, Chen Jennifer H, Larson Michael J, Vizesi Frank

机构信息

SeaSpine Inc., Carlsbad, CA, United States.

Surgical and Orthopaedic Research Laboratories, Prince of Wales Clinical School, University of New South Wales, Sydney, NSW, Australia.

出版信息

Front Surg. 2020 Mar 20;7:10. doi: 10.3389/fsurg.2020.00010. eCollection 2020.

DOI:10.3389/fsurg.2020.00010
PMID:32266283
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7099880/
Abstract

Demineralized bone matrix (DBM) is a widely used bone graft in spinal fusion. Most commercial DBMs are composed of demineralized bone particles (~125-800 microns) suspended in a carrier that provides improved handling but dilutes the osteoinductive component. DBM fibers (DBF) provide improved osteoconductivity and do not require a carrier. It has been suggested that 100% DBF may offer improved performance over particulate-based DBMs with carrier. Seven commercially available DBM products were tested in an athymic rat posterolateral fusion model. There were four 100% DBFs, two DBFs containing a carrier, and one particulate-based DBM containing carrier. The study objectives were to evaluate the performance: (1) compare fusion rate and fusion maturity of six commercially available DBFs and one particulate-based DBM, and (2) assess the effect of carrier on fusion outcomes for DBFs in a posterolateral fusion model. The DBF/DBM products evaluated were: Strand Family, Propel® DBM Fibers, Vesuvius® Demineralized Fibers, Optium® DBM Putty, Grafton® DBF, Grafton Flex, and DBX® Putty. Single-level posterolateral fusion was performed in 69 athymic rats. Fusion was assessed bilaterally after 4 weeks by manual palpation, radiograph and CT for bridging bone. Fusion mass maturity was assessed with a CT maturity grading scale and by histology. Statistical analysis was performed using Fishers Exact Test for categorical data and Kruskal-Wallis Test for non-parametric data. Strand Family achieved 100% fusion (18/18) by manual palpation, radiographic and CT evaluation, significantly higher than Propel Fibers, Vesuvius Fibers, Optium Putty, and DBX Putty, and not statistically higher than Grafton DBF and Grafton Flex. Strand Family provided the highest fusion maturity, with CT maturity grade of 2.3/3.0 and 89% mature fusion rate. Fusion results suggest a detrimental effect of carrier on fusion performance. There were large variations in fusion performance for seven commercially available DBM products in an established preclinical fusion model. There were even significant differences between different 100% DBF products, suggesting that composition alone does not guarantee performance. In the absence of definitive clinical evidence, surgeons should carefully consider available data in valid animal models when selecting demineralized allograft options.

摘要

脱矿骨基质(DBM)是脊柱融合术中广泛使用的骨移植材料。大多数市售的DBM由悬浮在载体中的脱矿骨颗粒(约125 - 800微米)组成,载体改善了其操作性,但稀释了骨诱导成分。DBM纤维(DBF)具有更好的骨传导性,且不需要载体。有人提出,100%的DBF可能比含载体的颗粒状DBM性能更好。在无胸腺大鼠后外侧融合模型中对七种市售的DBM产品进行了测试。其中有四种100%的DBF、两种含载体的DBF和一种含载体的颗粒状DBM。研究目的是评估其性能:(1)比较六种市售DBF和一种颗粒状DBM的融合率和融合成熟度,(2)评估载体对后外侧融合模型中DBF融合结果的影响。所评估的DBF/DBM产品包括:Strand Family、Propel® DBM纤维、Vesuvius®脱矿纤维、Optium® DBM油灰、Grafton® DBF、Grafton Flex和DBX®油灰。对69只无胸腺大鼠进行了单节段后外侧融合手术。4周后通过手动触诊、X线片和CT检查双侧是否有桥接骨来评估融合情况。用CT成熟度分级量表和组织学方法评估融合块的成熟度。使用Fisher精确检验对分类数据进行统计分析,使用Kruskal - Wallis检验对非参数数据进行统计分析。通过手动触诊、X线片和CT评估,Strand Family实现了100%的融合(18/18),显著高于Propel纤维、Vesuvius纤维、Optium油灰和DBX油灰,在统计学上不高于Grafton DBF和Grafton Flex。Strand Family的融合成熟度最高,CT成熟度等级为2.3/3.0,成熟融合率为89%。融合结果表明载体对融合性能有不利影响。在一个成熟的临床前融合模型中,七种市售DBM产品的融合性能存在很大差异。不同的100% DBF产品之间甚至存在显著差异,这表明仅成分并不能保证性能。在缺乏确凿临床证据的情况下,外科医生在选择脱矿同种异体移植选项时应仔细考虑有效动物模型中的现有数据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1240/7099880/e66ef4fd3e9b/fsurg-07-00010-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1240/7099880/60076ffb2fca/fsurg-07-00010-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1240/7099880/733df86ce84d/fsurg-07-00010-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1240/7099880/113c91f93d14/fsurg-07-00010-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1240/7099880/ce62ed351cf0/fsurg-07-00010-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1240/7099880/a6db0f9f5b98/fsurg-07-00010-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1240/7099880/e66ef4fd3e9b/fsurg-07-00010-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1240/7099880/60076ffb2fca/fsurg-07-00010-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1240/7099880/733df86ce84d/fsurg-07-00010-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1240/7099880/113c91f93d14/fsurg-07-00010-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1240/7099880/ce62ed351cf0/fsurg-07-00010-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1240/7099880/a6db0f9f5b98/fsurg-07-00010-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1240/7099880/e66ef4fd3e9b/fsurg-07-00010-g0006.jpg

相似文献

1
Performance of Seven Commercially Available Demineralized Bone Matrix Fiber and Putty Products in a Rat Posterolateral Fusion Model.七种市售脱矿骨基质纤维和糊剂产品在大鼠后外侧融合模型中的性能
Front Surg. 2020 Mar 20;7:10. doi: 10.3389/fsurg.2020.00010. eCollection 2020.
2
Comparative Efficacy of Commonly Available Human Bone Graft Substitutes as Tested for Posterolateral Fusion in an Athymic Rat Model.在无胸腺大鼠模型中对常用人工骨移植替代物进行后外侧融合测试的比较疗效
Int J Spine Surg. 2019 Oct 31;13(5):437-458. doi: 10.14444/6059. eCollection 2019 Oct.
3
Efficacy comparison of Accell Evo3 and Grafton demineralized bone matrix putties against autologous bone in a rat posterolateral spine fusion model.在大鼠后外侧脊柱融合模型中,Accell Evo3和Grafton脱矿骨基质糊剂与自体骨的疗效比较。
Spine J. 2017 Jun;17(6):855-862. doi: 10.1016/j.spinee.2017.01.012. Epub 2017 Jan 23.
4
New formulations of demineralized bone matrix as a more effective graft alternative in experimental posterolateral lumbar spine arthrodesis.脱矿骨基质的新配方作为实验性腰椎后外侧脊柱融合术中更有效的移植替代物。
Spine (Phila Pa 1976). 1999 Apr 1;24(7):637-45. doi: 10.1097/00007632-199904010-00005.
5
A comparison of commercially available demineralized bone matrices with and without human mesenchymal stem cells in a rodent spinal fusion model.在啮齿动物脊柱融合模型中,对含有人间充质干细胞和不含人间充质干细胞的市售脱矿骨基质进行比较。
J Neurosurg Spine. 2016 Jul;25(1):133-7. doi: 10.3171/2015.12.SPINE15737. Epub 2016 Mar 11.
6
Comparison of posterolateral lumbar fusion rates of Grafton Putty and OP-1 Putty in an athymic rat model.在无胸腺大鼠模型中比较Grafton补片和OP-1补片的腰椎后外侧融合率。
Spine (Phila Pa 1976). 2004 Aug 1;29(15):1612-7. doi: 10.1097/01.brs.0000132512.53305.a1.
7
Local effect of zoledronic acid on new bone formation in posterolateral spinal fusion with demineralized bone matrix in a murine model.唑来膦酸对小鼠模型中使用脱矿骨基质进行后外侧脊柱融合时新骨形成的局部作用。
Arch Orthop Trauma Surg. 2018 Jan;138(1):13-18. doi: 10.1007/s00402-017-2818-4. Epub 2017 Oct 10.
8
The efficacy of different commercially available demineralized bone matrix substances in an athymic rat model.不同市售脱矿骨基质物质在无胸腺大鼠模型中的疗效。
J Spinal Disord Tech. 2005 Oct;18(5):439-44. doi: 10.1097/01.bsd.0000175696.66049.f7.
9
Evaluation of a new formulation of demineralized bone matrix putty in a rabbit posterolateral spinal fusion model.在兔后外侧脊柱融合模型中对一种新型脱矿骨基质糊剂配方的评估。
Spine J. 2014 Sep 1;14(9):2155-63. doi: 10.1016/j.spinee.2014.01.053. Epub 2014 Feb 8.
10
A comparison of commercially available demineralized bone matrix for spinal fusion.用于脊柱融合的市售脱矿骨基质的比较。
Eur Spine J. 2007 Aug;16(8):1233-40. doi: 10.1007/s00586-006-0282-x. Epub 2007 Jan 5.

引用本文的文献

1
Transforming spinal surgery with innovations in biologics and additive manufacturing.通过生物制剂和增材制造方面的创新变革脊柱外科手术。
Mater Today Bio. 2025 May 13;32:101853. doi: 10.1016/j.mtbio.2025.101853. eCollection 2025 Jun.
2
Porcine Bone Extracellular Matrix Hydrogel as a Promising Graft for Bone Regeneration.猪骨细胞外基质水凝胶作为一种有前景的骨再生移植物
Gels. 2025 Feb 27;11(3):173. doi: 10.3390/gels11030173.
3
Characterization of non-solvent- and thermal-induced phase separation applied polycaprolactone/demineralized bone matrix scaffold for bone tissue engineering.

本文引用的文献

1
Comparative Efficacy of Commonly Available Human Bone Graft Substitutes as Tested for Posterolateral Fusion in an Athymic Rat Model.在无胸腺大鼠模型中对常用人工骨移植替代物进行后外侧融合测试的比较疗效
Int J Spine Surg. 2019 Oct 31;13(5):437-458. doi: 10.14444/6059. eCollection 2019 Oct.
2
Efficacy comparison of Accell Evo3 and Grafton demineralized bone matrix putties against autologous bone in a rat posterolateral spine fusion model.在大鼠后外侧脊柱融合模型中,Accell Evo3和Grafton脱矿骨基质糊剂与自体骨的疗效比较。
Spine J. 2017 Jun;17(6):855-862. doi: 10.1016/j.spinee.2017.01.012. Epub 2017 Jan 23.
3
用于骨组织工程的聚己内酯/脱矿骨基质支架的非溶剂和热诱导相分离表征
In Vitro Model. 2022 Apr 26;1(2):197-207. doi: 10.1007/s44164-022-00018-9. eCollection 2022 Apr.
4
Mesenchymal Stem Cell Exosomes Enhance Posterolateral Spinal Fusion in a Rat Model.间充质干细胞外泌体增强大鼠模型后路脊柱融合。
Cells. 2024 Apr 29;13(9):761. doi: 10.3390/cells13090761.
5
Demineralized Bone Matrix and Fibers in Spinal Fusion.脊柱融合术中的脱矿骨基质与纤维
Int J Spine Surg. 2023 Dec 27;17(S3):S28-S34. doi: 10.14444/8558.
6
Comparative Evaluation of Mineralized Bone Allografts for Spinal Fusion Surgery.脊柱融合手术中矿化骨同种异体移植的比较评估
J Funct Biomater. 2023 Jul 21;14(7):384. doi: 10.3390/jfb14070384.
7
Demineralized cortical fibers are associated with a low pseudarthrosis rate in patients undergoing surgery for adult spinal deformity without three-column osteotomy.脱矿质皮质纤维与未行三柱截骨术的成人脊柱畸形手术患者的假关节形成率较低相关。
Brain Spine. 2023 May 10;3:101751. doi: 10.1016/j.bas.2023.101751. eCollection 2023.
8
Comparison of demineralized bone matrix with different cycling crushing times in posterolateral fusion model of athymic rats.去胸腺大鼠后外侧融合模型中不同循环粉碎时间的脱矿骨基质比较
Cell Tissue Bank. 2023 Dec;24(4):747-758. doi: 10.1007/s10561-023-10086-0. Epub 2023 May 3.
9
Bone Mineralization in Electrospun-Based Bone Tissue Engineering.基于静电纺丝的骨组织工程中的骨矿化
Polymers (Basel). 2022 May 23;14(10):2123. doi: 10.3390/polym14102123.
10
Biocompatible Customized 3D Bone Scaffolds Treated with CRFP, an Osteogenic Peptide.用成骨肽CRFP处理的生物相容性定制3D骨支架
Bioengineering (Basel). 2021 Nov 30;8(12):199. doi: 10.3390/bioengineering8120199.
Bone substitutes and expanders in Spine Surgery: A review of their fusion efficacies.
脊柱手术中的骨替代物和扩张器:对其融合效果的综述
Int J Spine Surg. 2016 Sep 22;10:33. doi: 10.14444/3033. eCollection 2016.
4
A comparison of commercially available demineralized bone matrices with and without human mesenchymal stem cells in a rodent spinal fusion model.在啮齿动物脊柱融合模型中,对含有人间充质干细胞和不含人间充质干细胞的市售脱矿骨基质进行比较。
J Neurosurg Spine. 2016 Jul;25(1):133-7. doi: 10.3171/2015.12.SPINE15737. Epub 2016 Mar 11.
5
Brief Report: Human Perivascular Stem Cells and Nel-Like Protein-1 Synergistically Enhance Spinal Fusion in Osteoporotic Rats.简短报告:人血管周围干细胞与Nel样蛋白-1协同增强骨质疏松大鼠的脊柱融合
Stem Cells. 2015 Oct;33(10):3158-63. doi: 10.1002/stem.2103. Epub 2015 Sep 9.
6
Human perivascular stem cell-based bone graft substitute induces rat spinal fusion.基于人血管周围干细胞的骨移植替代物可诱导大鼠脊柱融合。
Stem Cells Transl Med. 2014 Oct;3(10):1231-41. doi: 10.5966/sctm.2014-0027. Epub 2014 Aug 25.
7
Use of demineralized bone matrix in spinal fusion.脱矿骨基质在脊柱融合术中的应用。
World J Orthop. 2014 Jan 18;5(1):30-7. doi: 10.5312/wjo.v5.i1.30.
8
11 kGy gamma irradiated demineralized bone matrix enhances osteoclast activity.11千戈瑞伽马射线辐照的脱矿骨基质增强破骨细胞活性。
Eur J Orthop Surg Traumatol. 2014 Jul;24(5):655-61. doi: 10.1007/s00590-013-1238-6. Epub 2013 May 25.
9
Grafton and local bone have comparable outcomes to iliac crest bone in instrumented single-level lumbar fusions.带骨块和取自髂嵴的松质骨在单节段腰椎融合术中的效果相当。
Spine (Phila Pa 1976). 2012 May 20;37(12):1083-91. doi: 10.1097/BRS.0b013e31823ed817.
10
Variability across ten production lots of a single demineralized bone matrix product.十种单一脱矿骨基质产品批间的变异性。
J Bone Joint Surg Am. 2010 Feb;92(2):427-35. doi: 10.2106/JBJS.H.01400.